CRISPR Therapeutics: From Genome Editing Basics To Clinical Applications

This content is brought to you by Integrated DNA Technologies, a Danaher Operating Company.

CRISPR is rapidly reshaping how genetic diseases are understood and treated, offering a more precise and scalable alternative to traditional gene therapy. Advances in genome editing now allow scientists to directly correct disease-causing mutations, opening new possibilities for addressing rare and complex conditions at their source. From foundational mechanisms like Cas nucleases and guide RNA design to emerging tools such as base and prime editing, the landscape continues to expand with greater flexibility and accuracy.

Equally critical are the challenges that sit between discovery and patient impact—delivery strategies, safety considerations, and the rigorous path through preclinical and clinical development. With growing clinical momentum and early therapeutic successes, CRISPR is moving steadily toward real-world application.

Find out how these innovations are shaping the future of medicine and what it takes to translate breakthrough science into viable therapies.